• Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

  • Jan 25 2024
  • Length: 58 mins
  • Podcast
Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion By cover art

Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

Listen for free

View show details

  • Summary

  • In this episode, Anthony and Bernie review the most impactful and interesting ALL abstracts at the 2023 ASH Annual Meeting. We dive into the nelarabine abstracts, calaspargase (cal-peg), and the evolution of the treatment of Ph+ ALL!


    Abstracts discussed:

    • https://ash.confex.com/ash/2023/webprogram/Paper190141.html - COG AYA Outcomes (and silly nelarabine conclusions)
    • https://ash.confex.com/ash/2023/webprogram/Paper177696.html - ATRIALL Nelarabine study
    • https://ash.confex.com/ash/2023/webprogram/Paper179562.html - HyperCVAD + Nelarabine + PEG + venetoclax
    • https://ash.confex.com/ash/2023/webprogram/Paper179192.html - ALL-TARGET Study in R/R T-ALL
    • https://ash.confex.com/ash/2023/webprogram/Paper187694.html - Cal-PEG is toxic
    • https://ash.confex.com/ash/2023/webprogram/Paper188064.html - Ponatinib + Blinatumomab
    • https://ash.confex.com/ash/2023/webprogram/Paper187773.html - D-ALBA (Dasatinib + Blinatumomab)
    • https://ash.confex.com/ash/2023/webprogram/Paper189632.html - GIMEMA (Dasatinib or Ponatinib + Blinatumomab)
    Show more Show less
Show more Show less

What listeners say about Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available